CMS understands that not all physicians will report quality measures under the Medicare Access and CHIP Reauthorization Act or join advanced alternative payment models, especially immediately, said Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS. However, there are efforts in place to make it as easy as possible for these providers, which will hopefully increase participation over time.
CMS understands that not all physicians will report quality measures under the Medicare Access and CHIP Reauthorization Act (MACRA) or join advanced alternative payment models (APMs), especially immediately, said Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS. However, there are efforts in place to make it as easy as possible for these providers, which will hopefully increase participation over time.
Transcript (slightly modified)
Is there a percentage of physicians that you expect will not report at least one quality measure under MACRA and will be facing penalties?
We hope that that number is minimal. We really, again, our goal is to have very high participation in this program, but certainly there are likely to be at least some clinicians who make the decision, that for whatever reason, that they don’t want to participate in the program. There may be some clinicians who aren’t aware of the program who don’t participate, although we’re really working hard to get the word out to every physician and eligible clinician in the country about this, using a lot of our surrogates and counting on the specialty societies and state medical societies to help with that.
But certainly, there is likely to be what we hope is a very small percentage of people who don’t do anything, and if you don’t participate at all, don’t send in any data, and you are eligible for the program, so you don’t go below the low-volume threshold for example, then you will get a 4% penalty.
How many physicians do you expect will be in advanced APMs under MACRA?
We think for 2017 that the number of clinicians that will be in advanced APMs is somewhere probably between 90,000 and 120,000. We hope that that number, we’re aiming for that number to increase significantly by 2018, so we could have as many as 200,000 to 250,000 clinicians be in advanced APMs.
Now again, remember in order for them to be exempt from MIPS [Merit-based Incentive Payment System] they have to have a certain percentage of their revenue from Medicare coming through that advanced APM, or a certain percentage of their patients being attributed to that advanced APM. But we’re optimistic with some of the things that we do plan to put in place over the next year, that will allow more and more clinicians to be eligible for these advanced APMs.
And then over time, of course, we anticipate that growing even further, particularly as the Physician Technical Advisory Committee, or the PTAC, is receiving applications for new physician-focused payment models. We anticipate a lot of those are going to be specialty focused, and many of those we hope will ramp up over time so those numbers will grow even more.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Overcoming Challenges to Value-Based Care Implementation: Grant Andres
November 10th 2023In an interview with The American Journal of Managed Care®, Grant Andres, BSc, DC, BSN, MSN-RN, senior director of clinical operations at Arizona Oncology, discussed the nuances of successfully implementing value-based care initiatives across a large organization.
Read More
Innovation in Value-Based Care Requires More Data, Patient-Centered Thinking
November 9th 2023In a panel discussion at the 2023 Patient-Centered Oncology Care® meeting held in Nashville, Tennessee, experts discussed the Enhancing Oncology Model and themes in the movement toward value-based care in oncology.
Read More